SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-074439
Filing Date
2023-03-20
Accepted
2023-03-20 08:00:59
Documents
12
Period of Report
2023-03-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d458829d8k.htm   iXBRL 8-K 22772
  Complete submission text file 0001193125-23-074439.txt   139963

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bioc-20230316.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bioc-20230316_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bioc-20230316_pre.xml EX-101.PRE 10812
6 EXTRACTED XBRL INSTANCE DOCUMENT d458829d8k_htm.xml XML 3266
Mailing Address 9955 MESA RIM ROAD SAN DIEGO CA 92121
Business Address 9955 MESA RIM ROAD SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 23744960
SIC: 8071 Services-Medical Laboratories